SSgA SPDR MSCI World Health Care UCITS ETF (AMS:WHEA)
Netherlands · Delayed Price · Currency is EUR | Assets | 423.55M |
| Expense Ratio | 0.30% |
| PE Ratio | 25.68 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -15.50% |
| Volume | 12,728 |
| Open | 51.98 |
| Previous Close | 52.15 |
| Day's Range | 51.47 - 52.00 |
| 52-Week Low | 48.90 |
| 52-Week High | 61.36 |
| Beta | n/a |
| Holdings | 121 |
| Inception Date | Apr 29, 2016 |
About WHEA
SSgA SPDR MSCI World Health Care UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. The fund is co-managed by State Street Global Advisors France S.A. It invests in the public equity markets of developed countries across the globe. The fund seeks to invest in the stocks of companies operating in the health care sector. It invests in the stocks of large-cap and mid-cap companies. The fund seeks to replicate the performance of the MSCI World Health Care Index, by investing in the stocks of companies as per their weightings in the index. SSgA SPDR MSCI World Health Care UCITS ETF was formed on April 29, 2016 and is domiciled in Ireland.
Performance
WHEA had a total return of -15.50% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.81%.
Top 10 Holdings
41.38% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 8.11% |
| Johnson & Johnson | JNJ | 5.85% |
| AbbVie Inc. | ABBV | 5.10% |
| UnitedHealth Group Incorporated | UNH | 3.86% |
| AstraZeneca PLC | AZN | 3.39% |
| Novartis AG | NOVN | 3.30% |
| Abbott Laboratories | ABT | 3.17% |
| Roche Holding AG | ROG | 3.15% |
| Merck & Co., Inc. | MRK | 2.90% |
| Thermo Fisher Scientific Inc. | TMO | 2.55% |